Skip to main content
  • Sign in
  • Help
BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2025
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Specialist Advisory Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Conference
    • Latest Conference 2025
    • Abstract Submission Opens 31st March
    • Past Symposiums / Conferences
  • News & Events
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Join BOPA
Join BOPA
BOPA Join BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2025
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Specialist Advisory Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Conference
    • Latest Conference 2025
    • Abstract Submission Opens 31st March
    • Past Symposiums / Conferences
  • News & Events
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Join BOPA

Home » Supportive care

Supportive care

BOPA encourages its members to share helpful documents that can benefit other members.  BOPA respects the intellectual property of original authors and requires anyone who uses other members’ work to include an acknowledgment of, or reference to, the source in their version.

DISCLAIMER:
BOPA is not the author or owner of some of the documents published on our website.  BOPA as a professional interest group will share documents via its website that are of interest to BOPA members, but has no responsibility for use of the documents and for any recommendations within the documents so members must use these at their discretion. BOPA cannot accept responsibility for any errors or omissions or for any consequences from application of information in the documents attached and make no warranty, expressed or implicit with respect to the contents of this webpage. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site or document(s) downloaded from it.

Posters and abstracts on the BOPA website remain the property of the authors and anyone wishing to reference or share this work must contact the authors directly. Abstracts subsequently published in JOPP follow copyright rules from JOPP.

Last reviewed: 22/03/23 by BOPA

Position Statement: BOPA supports the withdrawal of histamine 2 (H2) antagonists from paclitaxel pre-medication regimens following publication of research which demonstrates their lack of effect. January 2023

Positions Statements

View resources
Last reviewed: 06/12/22 by BOPA Committee

The Challenge & Success of Complex pain management in Cancer – Dr Marie Joseph (18th May 2022)

Webinar

View resources
Last reviewed: 08/10/21 by Rajinder Nijjar

A collaborative audit on DPYD testing of all patients initiated on fluoropyrimidines (5-fluorouracil, capecitabine and oral prodrug tegafur) across 5 London teaching hospitals

Abstracts

View resources
Last reviewed: 08/10/21 by David Martin

An Evaluation of Nausea Amongst Patients Prescribed High Emetogenic Risk Chemotherapy

Abstracts

View resources
Last reviewed: 08/10/21 by John Leggett

An audit to investigate adherence to antibiotic prescribing in neutropenic sepsis guidelines in haemato-oncology and solid-oncology patients

Abstracts

View resources
Last reviewed: 08/10/21 by Natalia Czub

Audit of oral cryotherapy for the prevention of oral mucositis in patients undergoing chemotherapy containing high dose melphalan prior to autologous hematopoietic stem cell transplantation (HSCT)

Abstracts

View resources
Last reviewed: 08/10/21 by Stephen Morris

Impact of concomitant steroids on mogamulizumab efficacy in MAVORIC

Abstracts

View resources
Last reviewed: 22/03/23 by Sana Mahmood

Multi centre retrospective evaluation of Paclitaxel hypersensitivity reactions in the absence of H2 antagonist pre-medication

Abstracts

View resources
Last reviewed: 08/10/21 by Nick Duncan

An investigation of the use of dexrazoxane as a cardioprotectant in UK Teenage and Young Adult (TYA) Cancer Centres

Abstracts

View resources
Last reviewed: 22/03/23 by Emma Foreman

A National Service Evaluation of Paclitaxel Pre medication Regimes for the Prevention of Hypersensitivity during a period of Ranitidine Shortage

Abstracts

View resources
Last reviewed: 22/03/23 by Emma Foreman

A Service Evaluation of Paclitaxel Hypersensitivity Reactions with and without Ranitidine Pre-medication at The Royal Marsden (RMH)

Abstracts

View resources
Last reviewed: 08/10/21 by Cheuk-kie Jackie Cheung

Efficacy of single 7.5 mg dose versus higher doses of rasburicase in the prevention of tumour lysis syndrome in adults with haematology malignancies

Abstracts

View resources

Filter for resources

  • Types

  • Tags

  • Reset

1 2 Next
BOPA logo
  • Why join BOPA
  • Pricing/Join
  • Conference 2024
  • Education
  • About
  • News & Events
  • Help
  • Go to LinkedIn
  • Go to Twitter
  • Go to Facebook
  • Go to Instagram
  • Go to Bluesky

© Copyright 2025 British Oncology Pharmacy Association.
Registered Charity No. 1065026

  • Privacy Policy
  • T&Cs Website
  • T&Cs Membership
  • Cookies
  • Contact
Designed and developed by Rouge
Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site. By continuing to browse the site, you are agreeing to our use of cookies.